К содержанию
РецензированоEN2023

MODERN APPROACHES TO DRUG TREATMENT OF OBESITY

Шагазатова Б.Х. · Кудратова Н.А.

ЦЕНТРАЛЬНО АЗИАТСКИЙ ЭНДОКРИНОЛОГИЧЕСКИЙ ЖУРНАЛ · 2023

Аннотация

Obesity is a chronic and relapsing disease that not only disrupts metabolism, but is also a risk factor for cardiovascular disease. Although behavioral therapy is important in treating obesity, it is difficult to reach the ideal weight and maintain long-term weight loss on its own. Therefore, obesity guidelines strongly recommend initiation of medication therapy in patients with BMI ≥30 kg/m 2 and BMI ≥27 kg/m 2 with concomitant weight-related diseases, such as DM2. There is ample evidence to support that pharmacotherapy combined with behavioral interventions can lead to significant weight loss and improved cardiometabolism. One strategy for long-term control of obesity is that weight loss medications should be individualized for each patient, depending on their comorbidities and preferences.

Доказательный фрагмент

«Obesity is a chronic and relapsing disease that not only disrupts metabolism, but is also a risk factor for cardiovascular disease.»

Образец извлечения

Демо-превью

Obesity is a chronic and relapsing disease that not only disrupts metabolism, but is also a risk factor for cardiovascular disease. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Просмотров
0
Тип
Журнал
Страна
Узбекистан
Спросить CiteX об этой работе

Смежные источники

[4]МедицинаRUРецензированоОткрытый доступ
BIOGEN ELEMENTLARNING INSON SALOMATLIGIDAGI O’RNI

Медицина, педагогика и технологии: теория и практикаТЕОРИЯ И ПРАКТИКА, Ne’matova F.O. +12024

5